• No results found

Formulation and Characterization of Patient-Friendly Dosage Form of Ondansetron Hydrochloride

N/A
N/A
Protected

Academic year: 2020

Share "Formulation and Characterization of Patient-Friendly Dosage Form of Ondansetron Hydrochloride"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Figure

Table 1: Formulation design Time (s) Before taste masking
Table 2: Volunteers’ opinion test for Ondansetron HCl before and after taste masking by a panel of nine members  using the time intensity method (n = 9)
Figure 2: X-ray diffraction pattern of (A) Ondansetron HCl, (B) indion  234 resin, (C) indion-234 resinate
Figure 5: Dissolution profile of control tablet, tablets containing sodium  starch  glycolate  containing  MCC  as  filler  binder  and  the  marketed  formulation

References

Related documents

Considering only women who received abortion care from public facility where there is shortage contraception supplies in study conducted in two of the region and failing to

It was decided that with the presence of such significant red flag signs that she should undergo advanced imaging, in this case an MRI, that revealed an underlying malignancy, which

Also, both diabetic groups there were a positive immunoreactivity of the photoreceptor inner segment, and this was also seen among control ani- mals treated with a

Many chemokines are secreted during inflammation, suggesting either a high degree of redundancy or an overlap in function. In vitro chemotaxis assays were set up using

If, however, the consent is caused by mistake the agreement is void.Such a contract where the consent of a party or parties to the contract is caused by any of the elements

In this paper we have studied the relation between download time of first chunk and the size of whole content if the bandwidth is limited in perspective of fixed upload rate in

Such workloads appear, for example, during the boot process of an operating system, where it checks the integrity of its components (see [‎15] for example). This

The primary end point of the study was the change from baseline in goblet cell density (determined by CIC) over the 3-month treatment period. Exploratory end